Navigation Links
Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
Date:9/10/2007

BERKELEY HEIGHTS, N.J. and RALEIGH, N.C., Sept. 10 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the appointments of Rajagopalan Srinivasan, Ph.D as Vice President, Global Biostatistics and Christopher Gregory, Ph.D as Scientific Affairs-Director.

"I am excited to have Drs. Srinivasan and Gregory, both highly experienced professionals in their respective fields in clinical research, join the Clinsys team," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "Dr. Srinivasan, who will head up our global biostatistics service offering, brings substantial expertise in biostatistics directly relating to our key therapeutic areas of Oncology, Cardiovascular and CNS. Dr. Gregory, who will serve as a senior scientific advisor for our clinical project teams, brings a wealth of direct pharmaceutical research development and academic experience to support our global regulatory and scientific affairs services."

Dr. Srinivasan has over 25 years of experience in biostatistics with regulated drug industry and medical research, including 10 years working at the FDA. He has held a number of senior management positions in the drug development industry, most recently as Vice President, Global Biostatistics with a global clinical research organization. During his tenure at the FDA, Dr. Srinivasan provided statistical guidance to regulated industry in each step of drug development (Pre-IND, IND, End of Phase II, pre-NDA, NDA as well as post-marketing Phase IV commitments). Dr. Srinivasan has taught Biostatistics/Statistics at the George Washington University, Washington, DC and is currently an adjunct Professor of Biostatistics at University of Virginia, Charlottesville, Virginia. He received his B. Sc. (Honors), M.A. and M. Phil degrees in Statistics from the University of Madras in India, his Masters in Biostatistics from Florida State University, Tallahassee, Florida and his Doctorate in Biostatistics from the University of Georgia, Athens, Georgia.

Dr. Gregory has over 15 years of biotechnology/pharmaceutical and academic experience. Prior to joining Clinsys, he served as Vice President, Research for Voyager Pharmaceutical Corporation in Raleigh, North Carolina. While at Voyager, he was responsible for directing all internal research programs and advising on external programs as they related to indications in CNS and Oncology, provided management of their laboratory and scientific teams, provided guidance in product development and participated in authoring patent applications as an inventor. Dr. Gregory was a Research Assistant Professor in The Laboratories for Reproductive Biology; Research Assistant Professor in the Department of Surgery, Division of Urology; Assistant Professor and currently serves as Adjunct Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill, North Carolina. He earned his Doctorate in Anatomy at Ohio State University in Columbus, Ohio and a Bachelor of Science Degree in Biology at Concord College in Athens, West Virginia.

"We continue to strive to provide our sponsors with the most complete service offering and the most qualified professional team in the industry, with our primary goal of ensuring the successful completion of their clinical development programs. Therapeutic expertise combined with a complete understanding of the drug development process from both the CRO and sponsor perspective, coupled with the highest level of service and quality is absolutely essential in attaining that goal. The addition of Drs. Srinivasan and Gregory to our high performance team will ensure that success," said Mr. Williams.

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company, headquartered in Berkeley Heights, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium; Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology companies a broad range of clinical research services in support of Phase I - IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas including oncology, cardiovascular, central nervous system, dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research, Ltd., located in Noida, India, provides extensive clinical research services for Phase I - IV drug development, and operates a clinical pharmacology unit which performs bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Targeted Clinical Staffing Solutions(TM) (TCSS - gotcss.com), a division of Clinsys Clinical Research, Inc., is a provider of professional staffing solutions and innovative partnering programs for the life sciences industry. For more information visit clinsyscro.com.

About Jubilant Organosys, Ltd.

Jubilant Organosys is an integrated pharmaceutical services provider, one of the largest custom research and manufacturing services (CRAMS), drug discovery and development services companies headquartered in India. Jubilant Organosys has more than 4,300 employees across organizations in India, the United States, Europe and China. It has four manufacturing locations in India and two in the United States. For more information visit jubl.com.

Clinsys Clinical Research and Targeted Clinical Staffing Solutions are registered trademarks of Clinsys Clinical Research, Inc.

Contact: Colin Coffua - Vice President, Global Marketing

+1 908 464 7500

ccoffua@clinsyscro.com


'/>"/>
SOURCE Clinsys Clinical Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Information Management Services ( IMS ) is pleased to ... completely new technical foundation and is so significant it was endowed with a new ... speed for search results, a streamlined layout and a more intuitive format for navigating ...
(Date:2/8/2016)... ... February 08, 2016 , ... Franz Inc. , an ... technology, today announced the availability of AllegroGraph 6, the leading Semantic Graph Database ... Certified Technology Program (CCPT). AllegroGraph is the first Semantic Graph Database to ...
(Date:2/8/2016)... has an active R&D program for the development of ... Group has a unique research and development center in ... Bio Control products. Stockton has a ... regulatory guidelines, and is active in more than 35 counties ... Stockton,s flagship product Timorex Gold ® ...
(Date:2/8/2016)... , February 8, 2016 ... ("Atlas Genetics" or the "Company"), the ultra-rapid Point-Of-Care (POC) molecular ... CE Mark its Chlamydia trachomatis (CT) test to be launched ... the IVD Directive (98/79/EC), the CT test is now cleared ... --> The launch of the io® CT ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 Vigilant Solutions announces today that ... Missouri solved two recent hit-and-run ... data from Vigilant Solutions. Brian Wenberg ... the victim was walking out of a convenience store and witnessed an elderly ... his vehicle, striking his vehicle and leaving the scene.  ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
Breaking Biology News(10 mins):